Synopsys Inc. Files 10-Q for Q2 2024

Ticker: SNPS · Form: 10-Q · Filed: 2024-05-24T00:00:00.000Z

Sentiment: neutral

Topics: 10-Q, financials, software

Related Tickers: SNPS

TL;DR

SNPS 10-Q filed: Q2 2024 results out. Check financials.

AI Summary

Synopsys Inc. filed its 10-Q for the period ending April 30, 2024. The company reported financial results for its second fiscal quarter of 2024. Key financial data and operational details are presented in this filing, which covers the period from February 1, 2024, to April 30, 2024.

Why It Matters

This filing provides investors and analysts with the latest financial performance and operational updates for Synopsys Inc., crucial for understanding the company's current standing and future prospects in the semiconductor and software industry.

Risk Assessment

Risk Level: low — This is a routine quarterly financial filing (10-Q) and does not inherently present new risks.

Key Players & Entities

FAQ

What is the reporting period for this 10-Q filing?

The Conformed Period of Report is 20240430, indicating the period ending April 30, 2024.

When was this 10-Q filed with the SEC?

This 10-Q was filed on 20240524.

What is Synopsys Inc.'s fiscal year end?

Synopsys Inc.'s fiscal year ends on 1031 (October 31).

What is the SIC code for Synopsys Inc.?

The Standard Industrial Classification code for Synopsys Inc. is 7372, which corresponds to SERVICES-PREPACKAGED SOFTWARE.

What are the business and mail addresses for Synopsys Inc.?

The business and mail address for Synopsys Inc. is 675 ALMANOR AVE, SUNNYVALE, CA 94085.

Filing Stats: 4,534 words · 18 min read · ~15 pages · Grade level 16.4 · Accepted 2024-05-24 16:31:20

Key Financial Figures

Filing Documents

Financial Information

PART I. Financial Information 1

Financial Statements (Unaudited)

Item 1. Financial Statements (Unaudited) 1 Condensed Consolidated Balance Sheets 1 Condensed Consolidated Statements of Income 3 Condensed Consolidated Statements of Comprehensive Income 5 Condensed Consolidated Statements of Stockholders' Equity 6 Condensed Consolidated Statements of Cash Flows 7 Notes to Condensed Consolidated Financial Statements 8

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 32

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 47

Controls and Procedures

Item 4. Controls and Procedures 48

Other Information

PART II. Other Information 49

Legal Proceedings

Item 1. Legal Proceedings 49

Risk Factors

Item 1A. Risk Factors 50

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 69

Other Information

Item 5. Other Information 69

Exhibits

Item 6. Exhibits 70

Signatures

Signatures 72

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements SYNOPSYS, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited, in thousands, except par value amounts) April 30, 2024 October 31, 2023 ASSETS Current assets: Cash and cash equivalents $ 1,502,920 $ 1,433,966 Short-term investments 156,780 151,639 Total cash, cash equivalents and short-term investments 1,659,700 1,585,605 Accounts receivable, net 834,918 856,660 Inventories 377,875 325,590 Prepaid and other current assets 760,269 548,115 Current assets held for sale 1,020,358 114,654 Total current assets 4,653,120 3,430,624 Property and equipment, net 566,832 549,837 Operating lease right-of-use assets, net 528,011 559,923 Goodwill 3,427,424 3,346,065 Intangible assets, net 276,877 239,577 Deferred income taxes 1,004,660 853,526 Other long-term assets 554,913 444,820 Long-term assets held for sale — 908,759 Total assets $ 11,011,837 $ 10,333,131 LIABILITIES, REDEEMABLE NON-CONTROLLING INTEREST AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable and accrued liabilities $ 635,916 $ 1,059,914 Operating lease liabilities 84,550 79,832 Deferred revenue 1,457,282 1,559,461 Current liabilities held for sale 330,602 286,244 Total current liabilities 2,508,350 2,985,451 Long-term operating lease liabilities 543,207 579,686 Long-term deferred revenue 307,965 150,827 Long-term debt 16,960 18,078 Other long-term liabilities 446,514 381,531 Long-term liabilities held for sale — 33,257 Total liabilities 3,822,996 4,148,830 Redeemable non-controlling interest 31,043 31,043 Stockholders' equity: Preferred stock, $ 0.01 par value: 2,000 shares authorized; none outstanding — — Common stock, $ 0.01 par value: 400,000 shares authorized; 153,204 and 152,053 shares outstanding, respectively 1,532 1,521 Capital in excess of par value 1,182,829 1,276,152 Retained earnings 7,478,366 6,741,699 Treasury stock, at cost: 4,056 and 5,207 shares, respectively ( 1,321,554 ) ( 1,675,650 ) Accumulated

View on Read The Filing